Hatcher J Ballard

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 2

Top Topics

Regulatory T Cells

Prognostic Factors

Top Venues

Cancer discovery

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Ruchi P Patel, Guido Ghilardi, Yunlin Zhang, Yi-Hao Chiang, Wei Xie, Puneeth Guruprasad, Ki Hyun Kim, Inkook Chun, Mathew G Angelos, Raymone Pajarillo, Seok Jae Hong, Yong Gu Lee, Olga Shestova, Carolyn Shaw, Ivan Cohen, Aasha Gupta, Trang Vu, Dean Qian, Steven Yang, Aditya Nimmagadda, Adam E Snook, Nicholas Siciliano, Antonia Rotolo, Arati A Inamdar, Jaryse Harris, Ositadimma Ugwuanyi, Michael Wang, Alberto Carturan, Luca Paruzzo, Linhui Chen, Hatcher J Ballard, Tatiana Blanchard, Chong Xu, Mohamed Abdel-Mohsen, Khatuna Gabunia, Maria Wysocka, Gerald P Linette, Beatriz Carreno, David M Barrett, David Trent Teachey, Avery D Posey, Daniel J Powell, Christopher Tor Sauter, Stefano A Pileri, Vinodh Pillai, John Scholler, Alain H Rook, Stephen J Schuster, Stefan Klaus Barta, Patrizia Porazzi, Marco Ruella
CD5 deletion enhances the antitumor activity of adoptive T cell therapies. Science immunology 9 (97) (2024)
Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, Raymone Pajarillo, Christopher Tor Sauter, Ruchi P Patel, Hatcher J Ballard, Seok Jae Hong, Inkook Chun, Nicholas Yang, Kimberly V Amelsberg, Katherine D Cummins, Jakub Svoboda, Saar I Gill, Elise A Chong, Khrystyna North, Sarah E Church, Joseph A Fraietta, Wan-Jung Chang, Simon F Lacey, Xueqing Maggie Lu, Yunlin Zhang, Kanupriya Whig, David C. Schultz, Sara Cherry, James Gerson, Stephen J Schuster, Patrizia Porazzi, Marco Ruella
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer. Cancer discovery 12 (10) (2022)